US Patent Issued to OrphAl Therapeutics on March 31 for "Apilimod compositions and methods of use" (New Jersey Inventor)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,097, issued on March 31, was assigned to OrphAl Therapeutics Inc. (New Haven, Conn.).

"Apilimod compositions and methods of use" was invented by Peter Ronald Young (Short Hills, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compositions and methods related to the use of apilimod alone or in combination with glutamatergic agents or other agents for treating neurological diseases and disorders, and for the treatment of cancer."

The patent was filed on Aug. 3, 2023, under Application No. 18/230,099.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sec...